TENS

https://journals.lww.com/otology-neurotology/Abstract/9000/Transcutaneous_Electrical_Nerve_Stimulation_for.96107.aspx

https://www.ncbi.nlm.nih.gov/pubmed/32472915?dopt=Abstract

TITLE:
Transcutaneous Electrical Nerve Stimulation for Treatment of Tinnitus: A Systematic Review and Meta-Analysis.

DESCRIPTION:
Transcutaneous Electrical Nerve Stimulation for Treatment of Tinnitus: A Systematic Review and Meta-Analysis.

Otol Neurotol. 2020 May 28;:

Authors: Byun YJ, Lee JA, Nguyen SA, Rizk HG, Meyer TA, Lambert PR

Abstract

OBJECTIVE: To evaluate the treatment efficacy of transcutaneous electrical nerve stimulation (TENS) in patients with tinnitus.

DATA SOURCES: PubMed, Scopus, Web of Science, and Cochrane Library were searched for the following concepts: “Transcutaneous Electric Nerve Stimulation” and “Tinnitus.”

STUDY SELECTION: Inclusion: 1) double- or single-blinded randomized controlled trials; 2) double- or single-blinded randomized comparison trials; 3) prospective or retrospective observational studies; and 4) case series. Exclusion: Non-English studies, nonhuman studies, case reports (n ≤ 5), and review articles.

DATA EXTRACTION: Tinnitus Handicap Inventory (THI), the Visual Analog Scale (VAS), and perceived tinnitus suppression after treatment. Additional data collected included tinnitus laterality, duration of symptoms, location of electrode placement, time to follow-up, etiology of tinnitus, and treatment side effects.

DATA SYNTHESIS: The literature search yielded 2941 unique articles. After reviewing 118 full-text articles, 17 studies reporting on 1,215 patients were included for final analysis. Four studies provided data available for meta-analysis of pre- and posttreatment THI and VAS (Cochrane Review Manager). TENS showed significant overall reduction on THI (-7.55 [-10.93 to -4.18], p < 0.0001) and VAS (-0.65 [-0.99 to -0.30], p < 0.0002). Subjective improvement of tinnitus was pooled across 13 studies using meta-analysis of proportions (MedCalc). Tinnitus suppression occurred in 40.0% [28.9-51.7%] patients. Among those who responded, 22.2% [12.2-29.7%] experienced complete suppression and 10.2% [0.2-31.9%] experienced persistent improvement at 3 months. CONCLUSIONS: TENS represents a safe and feasible treatment option for tinnitus and might be a worthy consideration among the spectrum of interventions developed for tinnitus. PMID: 32472915 [PubMed - as supplied by publisher] PMID: PubMed:32472915 DATE FOUND: 05/31/20 06:01AM LINK / URL: https://www.ncbi.nlm.nih.gov/pubmed/32472915?dopt=Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31732303?dopt=Abstract

The effect of transcutaneous electrical nerve stimulation (TENS) on chronic subjective tinnitus.

Am J Otolaryngol

Related Articles

The effect of transcutaneous electrical nerve stimulation (TENS) on chronic subjective tinnitus.

Am J Otolaryngol. 2019 Oct 29;:102326

Authors: Tutar B, Atar S, Berkiten G, Üstün O, Kumral TL, Uyar Y

Abstract

OBJECTIVES: Chronic Subjective Tinnitus is a very highly prevalent disorder worldwide. There is no definitive treatment. The aim of this study is to investigate the efficacy of transcutaneous electrical nerve stimulation (TENS) applied to the auricula for treating tinnitus using the Depression Anxiety Stress Scales (DASS) and Tinnitus Handicap Inventory (THI).

METHODS: The 60 patients were randomly divided into 3 groups of 20 patients. The first group (A) had one ear stimulated with TENS, and the second group (B) had both ears stimulated. Group C (placebo group) received no electrical or sound stimulation. All group patients received total of 10 sessions with a maximum of 4 days between the sessions.

RESULTS: The THI and DASS scores decreased significantly after the treatment (p < 0.05). A significant difference was also observed between the groups after treatment (p < 0.05). While there was no difference between group A and B, it was shown that group C's post-treatment score was significantly higher than those of both groups (p < 0.05.) CONCLUSION: It is important to note that TENS has a therapeutic effect on subjective chronic tinnitus as well as a placebo effect. PMID: 31732303 [PubMed - as supplied by publisher] PubMed:31732303